Related Experiment Video
Updated: Jan 24, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade
Dianne Pulte1, Janick Weberpals1, Lina Jansen1
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Background:
Several new treatments that improve survival in clinical trials have been developed for various solid malignancies in advanced stages. The effect of these options on survival in the general population is currently unknown.
Methods:
Cancers for which 2 or more new treatment options have been approved by the US Food and Drug Administration during the years 2009 through 2011 for the treatment of advanced disease were identified, including adenocarcinoma of the lung, melanoma, breast cancer, prostate cancer, and renal cell carcinoma. Kaplan-Meier analysis was used to compare overall survival for these conditions in the Surveillance, Epidemiology, and End Results database for the periods 2007 to 2008, 2009 to 2010, and 2011 to 2012. Hazard ratios derived from adjusted, shared frailty models for cancer-specific survival were calculated as well for the years of diagnosis (2007-2008, 2009-2010, and 2011-2012).
Results:
Two-year survival increased for patients with advanced-stage lung adenocarcinoma (+3.0 percentage points), melanoma (+3.4 percentage points), and breast cancer (+2.7 percentage points). When only patients aged 15 to 64 years were included, 2-year survival for those with melanoma increased by +6.7 percentage points. No change in survival was observed for renal cell carcinoma. Decreases in the hazard ratio for cancer-specific mortality were observed during the period 2011 to 2012 compared with 2007 to 2008 for lung adenocarcinoma, melanoma, and breast cancer.
Conclusions:
Small increases in 2-year survival were observed between the periods 2007 to 2008 and 2011 to 2012 for lung adenocarcinoma, melanoma, and prostate cancer. Cancer-specific mortality decreased for each of these cancers among patients who were diagnosed between the periods 2007 to 2008 and 2011 to 2013. These findings suggest that newer treatment options are beginning to increase survival for stage IV cancers at the population level.
Insights
New cancer treatments are improving survival rates for advanced lung adenocarcinoma, melanoma, and breast cancer patients in the general population. These advancements indicate a positive trend for stage IV cancer outcomes.
Area of Science:
- Oncology
- Public Health
- Cancer Research
Background:
- Advanced solid malignancies pose significant survival challenges.
- Clinical trials show promise for new treatment options.
- Population-level impact of these treatments remains largely unquantified.
Observation:
- The study analyzed survival data for lung adenocarcinoma, melanoma, breast, prostate, and renal cell carcinoma.
- Kaplan-Meier analysis and hazard ratio models assessed survival trends.
- Data spanned periods before and after new treatment approvals (2007-2012).
Findings:
- Two-year survival increased for advanced lung adenocarcinoma, melanoma, and breast cancer.
- Significant survival gains were noted in younger melanoma patients (15-64 years).
- Cancer-specific mortality decreased for lung adenocarcinoma, melanoma, and breast cancer.
Implications:
- Newer treatments are beginning to demonstrate a positive impact on population-level survival for stage IV cancers.
- These findings highlight the importance of real-world data in evaluating treatment efficacy.
- Further research is warranted to explore long-term survival benefits and specific treatment contributions.
Related Concept Videos
Conservation of Small Populations
Levels of Organization
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

